Abstract
Objective: This study aimed to evaluate the effect of the provision of drug-related information and patient education booklets on the hemoglobin A1c(HbA1c) levels of patients with type 2 diabetes mellitus.Methods: This prospective study was conducted at the Kembangan Health Center, West Jakarta, Indonesia, from March to June 2017. A total of30 patients were divided into two equal groups: In addition to routine treatment, patients in the intervention group received drug-related informationand patient education booklet, while those in the control group received no additional intervention. The provision of drug information was throughdirect education as well as through telephone, short messages, and booklet. HbA1c level was measured as a surrogate measure of treatment adherence.HbA1c concentration was measured at baseline and 11 weeks after the intervention.Results: Mean HbA1c level in the intervention group decreased from 8.05±0.91% at week 0 to 6.92±0.47% at week 11 after intervention (p<0.05).Conclusion: In this study, provision of drug information and patient education booklets helped to improve the patient compliance.
Highlights
Diabetes mellitus (DM) is a metabolic disorder characterized by high blood glucose levels caused by insufficient insulin
Patients were divided into two groups: Intervention group received drug information and booklet, while the control group did not receive drug information and booklet
This study indicates that pharmacists can play a key role in improving treatment compliance among patients with type 2 DM by interventions, such as provision of drug information, booklet, and follow-up reminders through short message service (SMS)
Summary
Diabetes mellitus (DM) is a metabolic disorder characterized by high blood glucose levels caused by insufficient insulin. According to the International Diabetes Federation [1], the global prevalence of DM in 2014 was 8.3%, which corresponded to a caseload of 387 million patients. Indonesia has the seventh highest incidence of DM in the world after China, India, United States, Brazil, Russia, and Mexico. The estimated number of diabetic patients in Indonesia is 8.5 million [1]. Poor disease management and low adherence lead to poor drug efficacy [2]. Monitoring of hemoglobin A1c (HbA1c) levels every 3 months helps monitor glycemic control to ensure treatment efficacy. High level of HbA1c reflects poor diabetic control owing to low adherence to treatment [3]
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
